Leading Health and LGBTQ+ Organisations Gather to Address the Need for LGBTQ+ Inclusive Health Systems and Evidence-Informed Care for Transgender People 14 October 2024 CAPE TOWN, South Africa – The Desmond Tutu Health Foundation (DTHF) and the University of Cape Town’s Faculty of Health Sciences, in partnership with Inclusive and Affirming Ministries (IAM), the Triangle…
South Africa and Uganda – 20. AUGUST 2024 – The Desmond Tutu Health Foundation (DTHF), Africa Health Research Institute (AHRI) and Medical Research Council/Uganda Virus Research Institute are excited to announce the enrollment of their first study participants in the groundbreaking MOBILE MEN Programme. MOBILE MEN is a pioneering initiative aimed at informing the implementation…
On 29 May 2023 Ugandan President Yoweri Museveni signed the Anti-Homosexuality Act, 2023 into law, declaring consensual same-sex sexual activities and any “promotion” of homosexuality a punishable criminal offence. The new law incorporates penalties that include a death sentence for cases of sexual relations involving people infected with HIV, repeated offences, minors, and other vulnerable…
We, the Desmond Tutu Health Foundation and partners, strongly condemn the Anti-Homosexuality Bill passed in the Ugandan Parliament on 21 March 2023. This a gross infringement of human rights and dignity and undermines sound public health policy. As an organisation in the name of the late Archbishop Emeritus Tutu, we are particularly concerned regarding the…
The Desmond Tutu HIV Foundation greets with great disappointment yesterday’s announcement from Johnson & Johnson and partners that the Imbokodo study, a large-scale HIV vaccine proof-of-concept study (HVTN 705) did not show sufficient levels of efficacy to continue the trial to completion. The results showed that the Adenovirus26-based mosaic vaccine regimen, while safe, did not…
10 November 2020 – The Desmond Tutu HIV Centre and Health Foundation welcome the announcement that another trial of long-acting injectable antiretroviral cabotegravir has demonstrated safety and efficacy in the prevention of HIV in cisgender women in Africa. Study sponsors ViiV, NIAID and the HPTN announced yesterday that the randomised part of the landmark trial…
*The following press release was published by African Alliance on Monday 09 November 2020. South Africa’s newest COVID-19 vaccine trial is another crucial step in ensuring a future vaccine works for South Africans and should be commended, says advocacy group the African Alliance and partner, the Vaccine Advocacy Resource Group. “Historically, Africa has had…
The Desmond Tutu Health Foundation welcomes the positive opinion of the European Medicines Agency on the monthly dapivirine vaginal ring for use by cisgender women over the age of 18 in developing countries to reduce their risk of HIV-1 infection. “Women in Africa have been left behind by progress against HIV for far too long,…
We are excited to announce that we are changing the name of our organisation to the Desmond Tutu Health Foundation. This move represents the widening scope of our work in public health research and community-driven health responses. Our name change acknowledges our expanding expertise that, directly or indirectly, contribute to our fight against HIV. “There…